MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
|
Back to Search Results |
|
Model Number 3058 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Unspecified Infection (1930); Pain (1994); Weakness (2145); Urinary Frequency (2275); Discomfort (2330); Complaint, Ill-Defined (2331); Sleep Dysfunction (2517); Weight Changes (2607)
|
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/ sacral nerve stimulation and gastrointestinal/ pelvic floor.It was reported that the patient was having so much pain in their bladder and on the right side where the ins is that they had trouble sleeping and can only sleep on the left side.The patient wondered if they had an infection, they had problems with pain around the ins for a couple years.The patient had their husband turn it off and still had pain all around where the ins is.The patient reported losing 25 lbs.The patient felt better since they turned it off but said it felt like there was a wire between their legs when they are together.The patient said it might be the wire placement or something and their bladder has hurt so bad when they have it on that it weakens them in the night, and they must get up to use the bathroom about 4 times a night.The patient said that when they complained about it before they were told to take ibuprofen, but they have a history of a gi bleeding, so they are not supposed to.The patient said they have been in so much pain that they are taking it anyway with food which gives them some relief for 2 hours.The patient would like to ask their healthcare professional about having it removed.The patient was redirected to follow up with their healthcare professional.No further complications were reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the consumer.They did not know the cause of pain around the ins.They did not know if there was an infection, but the implant site had been sore.Steps taken to resolve the possible infection were that an hcp changed stimulation which caused so much discomfort when lying down that they had to reduce stimulation.They took pills for discomfort.The issue had not resolved completely, but it had improved somewhat, especially after turning off stimulation and sleeping on the other side.They plan to have the device removed.No further device issue alleged / identified.No further patient symptoms or complications were reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|